Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Roivant Sciences Ltd’s stock clocked out at $20.24, down -0.93% from its previous closing price of $20.43. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 4.84 million shares were traded. ROIV stock price reached its highest trading level at $20.555 during the session, while it also had its lowest trading level at $20.135.
Ratios:
To gain a deeper understanding of ROIV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 33.70 and its Current Ratio is at 33.70. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Citigroup on September 02, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $17.Wolfe Research initiated its Outperform rating on February 15, 2024, with a $17 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 09 ’25 when Venker Eric bought 200,000 shares for $20.85 per share.
MANCHESTER KEITH S sold 1,300,000 shares of ROIV for $26,304,500 on Nov 19 ’25. The Director now owns 18,047,727 shares after completing the transaction at $20.23 per share. On Nov 19 ’25, another insider, Gold Daniel Allen, who serves as the Director of the company, sold 1,300,000 shares for $20.23 each. As a result, the insider received 26,304,500 and left with 18,047,727 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 14076749824 and an Enterprise Value of 10232888320. For the stock, the TTM Price-to-Sale (P/S) ratio is 692.41 while its Price-to-Book (P/B) ratio in mrq is 3.20. Its current Enterprise Value per Revenue stands at 503.364 whereas that against EBITDA is -9.232.
Stock Price History:
The Beta on a monthly basis for ROIV is 1.23, which has changed by 0.719697 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, ROIV has reached a high of $21.48, while it has fallen to a 52-week low of $8.73. The 50-Day Moving Average of the stock is 6.23%, while the 200-Day Moving Average is calculated to be 51.55%.
Shares Statistics:
It appears that ROIV traded 8.24M shares on average per day over the past three months and 5589720 shares per day over the past ten days. A total of 689.70M shares are outstanding, with a floating share count of 432.70M. Insiders hold about 37.79% of the company’s shares, while institutions hold 63.75% stake in the company. Shares short for ROIV as of 1764288000 were 20914523 with a Short Ratio of 2.54, compared to 1761868800 on 24528207. Therefore, it implies a Short% of Shares Outstanding of 20914523 and a Short% of Float of 4.01.
Earnings Estimates
A comprehensive evaluation of Roivant Sciences Ltd (ROIV) is underway, with the input of 4.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.25 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$0.86 and -$1.46 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is -$1.19, with 4.0 analysts recommending between -$0.74 and -$1.9.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $6.14M. It ranges from a high estimate of $15M to a low estimate of $1.78M. As of. The current estimate, Roivant Sciences Ltd’s year-ago sales were $9.02MFor the next quarter, 8 analysts are estimating revenue of $6.75M. There is a high estimate of $15M for the next quarter, whereas the lowest estimate is $2M.
A total of 10 analysts have provided revenue estimates for ROIV’s current fiscal year. The highest revenue estimate was $33.7M, while the lowest revenue estimate was $3.74M, resulting in an average revenue estimate of $15.9M. In the same quarter a year ago, actual revenue was $29.05MBased on 10 analysts’ estimates, the company’s revenue will be $118.02M in the next fiscal year. The high estimate is $466.13M and the low estimate is $6.28M.
